Talk:Wortmannin

From Wikipedia, the free encyclopedia

Molecular and Cellular Biology WikiProject This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme.
Stub This article has been rated as stub-Class on the assessment scale.
Low This article is on a subject of low-importance within molecular and cellular biology.

Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need.

Wortmannin is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start This article has been rated as start-Class on the quality scale.
Low This article has been rated as low-importance for this Project's importance scale.

Chemicals WikiProject Wortmannin is within the scope of WikiProject Chemicals, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.
Chemistry WikiProject This article is also supported by WikiProject Chemistry.
Start This article has been rated as start-Class on the quality scale.
Low This article has been rated as low-importance on the importance scale.

Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need.

[edit] MAPK and wortmannin

Not sure if this is true. Is MAPK inhibited by Wortmannin? It's not a commonly described target of wortmannin. What concentration is required to inhibit MAPK? Jagowins 17:47, 19 January 2006 (UTC)


Why not? read this: Adv Exp Med Biol. 1996;416:321-6. PAF-induced MAPK activation is inhibited by wortmannin in neutrophils and macrophages. Ferby I, Waga I, Kume K, Sakanaka C, Shimizu T.

AbuAmir 12:25, 30 April 2006 (UTC)


Maybe it would be a good idea for *someone* to put that reference in the article where the claim is made... Aaadddaaammm 09:12, 4 September 2006 (UTC)


I'm almost positive that Wortmannin has a longer half-life than 10 minutes. In the lab I work for, we use it in cell culture for 48-hour treatments and still see its effect as an inhibitor. Someone might want to reevaluate that tid-bit on the page describing Wortmannin.

[edit] Specific Inhibitor

I would argue that since Wortmannin inhibits : "mTOR, DNA-PK, some phosphatidylinositol 4-kinases, myosin light chain kinase (MLCK) and mitogen-activated protein kinase (MAPK) at high concentrations as well as members of the polo-like kinase family with IC50 in the same range as for PI3K." I will change this in a couple of days if no-one has any objections. ImmunolPhD 08:19, 26 July 2007 (UTC)

[edit] Wortmannin derivates going preclinicals

Please comrades, add a section about that. AbuAmir (talk) 12:10, 15 April 2008 (UTC)